In patients with an acute cerebrovascular bleed, should graduated anti‑embolic stockings be used for deep‑vein thrombosis prophylaxis, and what are the appropriate timing, pressure settings, duration, and contraindications?

Do Not Use Graduated Anti-Embolic Stockings Alone in Cerebrovascular Bleed

Graduated anti-embolic compression stockings should NOT be used for DVT prophylaxis in patients with acute cerebrovascular hemorrhage 1, 2, 3, 4. Multiple high-quality guidelines explicitly recommend against their use, with evidence showing no benefit and increased risk of skin complications.

Recommended VTE Prophylaxis Strategy

First-Line: Intermittent Pneumatic Compression (IPC)

For immobilized patients with intracerebral hemorrhage, use thigh-high intermittent pneumatic compression devices as the primary mechanical prophylaxis 1, 2, 4.

Timing and Implementation:

• Apply IPC devices as soon as possible, ideally within the first 24 hours of admission 1, 2
• Continue until the patient becomes independently mobile, at hospital discharge, or by 30 days (whichever comes first) 1, 2
• Assess skin integrity daily while devices are in use 1, 2
• If considering IPC after the first 24 hours, obtain venous leg Doppler studies first 1, 2

Pharmacological Prophylaxis: Delayed Initiation

For high-risk immobilized patients with intracerebral hemorrhage, pharmacological prophylaxis should be delayed at least 48 hours after hemorrhage onset 2, 3, 4.

Specific Protocol:

• Wait minimum 48 hours after stroke onset before initiating pharmacological prophylaxis 2
• Optimal timing appears to be 24-48 hours post-onset to balance thrombosis prevention against hemorrhage expansion risk 4
• Obtain repeat brain imaging demonstrating hematoma stability before starting anticoagulation 2
• Use prophylactic-dose LMWH (preferred) or unfractionated heparin (if renal failure present) 1, 2, 3

Why Graduated Compression Stockings Fail

The evidence against graduated compression stockings is particularly strong:

• No efficacy demonstrated: The CLOTS trial showed no significant reduction in symptomatic or asymptomatic DVT in stroke patients 5
• Increased harm: Significantly increased risk of lower-extremity skin damage (RR 4.02, absolute increase of 39 events per 1000 patients) 5
• Grade A evidence against use: Both Canadian and American guidelines provide Level A/Grade 1 evidence recommending against their use 1, 2, 3

Risk Stratification for VTE Prophylaxis

High-risk patients requiring prophylaxis include those with:

• Inability to move one or both lower limbs
• Inability to mobilize independently
• Previous history of venous thromboembolism
• Dehydration
• Comorbidities such as cancer 1, 2

Special Considerations for Hemorrhagic Stroke

Contraindications to Early Pharmacological Prophylaxis:

• Active intracranial hemorrhage within 48 hours
• Systemic hemorrhage
• Unstable hematoma on imaging 1, 2

If DVT/PE Develops Despite Prophylaxis:

• For proximal DVT in patients not yet candidates for anticoagulation: consider temporary retrievable IVC filter as bridge therapy 4
• For established proximal DVT or PE: delay treatment with UFH or LMWH for 1-2 weeks after ICH onset 4

Duration of Prophylaxis

• Continue mechanical prophylaxis until independent mobility is achieved 1, 2
• For patients remaining immobile beyond 30 days: continue pharmacological prophylaxis as long as immobility persists 1, 2

Common Pitfalls to Avoid

1. Do not use graduated compression stockings as sole prophylaxis - this is explicitly contraindicated with Grade A evidence 1, 2, 3
2. Do not start pharmacological prophylaxis in the first 48 hours - increased hemorrhage expansion risk 2, 3, 4
3. Do not forget daily skin assessment with IPC devices - skin breakdown is a recognized complication 1, 2
4. Do not delay IPC initiation - should begin within 24 hours when mechanical prophylaxis is chosen 1, 2

Adjunctive Measures

• Early mobilization when medically stable (after 24-48 hours, not within first 24 hours) 1, 2
• Adequate hydration 1, 2
• These measures alone are insufficient but complement mechanical/pharmacological prophylaxis